baber/WOPTO huggingface dataset:
Patent AU-2012265557-A1 (AU)
Title: Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
Inventor: HALL AMY JENNAE
IPC: A61K31/01
Filed: 2012-12-17
Abstract: C: \NRPortbl\DCC\DAR\489270_l.DOC-17 12/2012 Disclosed are botanically based compositions and methods useful for the treatment of metabolic syndrome and diabetes type 2. Compositions, kits, and methods are additionally disclosed for means to augment the activity of identified glucose and insulin regulating drugs. Hexahydrocolupulone _-^-7.1 0.57 Spent Hops : 1.11 Beta-Acids 1 .24 Alpha Acids sw ____ _ -' 1 1.45 -_- I _ _ ii _ Xanthohumol rrImm mm - 1.46 Hexahydroisoalpha acids Ir:".E 2 Tetrahydroisoalpha acids I m z m4 : 1.79 __I 'i__ f_ W Rho-isoaipha acids 2.25 Isoaipha acids -____ ____ 2.45 Indomethacin m_ _ ________ . 1.33 Troglitazone - --1 1.43 Solvent Control a 1.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 Relative Nonpolar Lipid Content WO 2007/070355 PCT/US2006/046770 Hexahydrocolupulone kv e L7.I 10.57 Spent Hops m re me m:I 1.11 Beta-Acids 1 m Thw's = - .24 Alpha Acids m n a m 1.45 Xanthohumol r a m a i -1 1.46 Hexahydroisoalpha acids amme-,r sa.a : - 1. 2 Tetrahydroisoalpha acids a mae r1- 1.79 Rho-isoalpha acids a -:" _________ : 2.25 Isoalpha acids a ____________n: 4 2.45 Indomethacin m22, mm5mfer : 1.33 Troglitazone 7,7 .7 77m75,777:77 i 1.43 Solvent Control mi - n ~ 1.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 Relative Nonpolar Lipid Content Fig. 18
Patent AU-2012273955-A1 (AU)
Title: Anti-Axl antibodies and uses thereof
Inventor: ROBERT BRUNO
IPC: C07K16/28
Filed: 2012-06-22
Abstract: The present invention relates to anti-Axl antibodies and uses thereof in diagnostic and therapeutic methods. More particularly, the present invention relates to a monoclonal antibody having specificity for Axl comprising an heavy chain variable region comprising SEQ ID NO:2 in the H-CDR1 region, SEQ ID NO:3 in the H-CDR2 region and SEQ ID NO:4 in the H-CDR3 region; and a light chain variable region comprising SEQ ID NO: 6 in the L- CDR1 region, SEQ ID NO:7 in the L-CDR2 region and SEQ ID NO:8 in the L-CDR3 region. Said monoclonal antibody binds to the extracellular domain of Axl via, SEQ ID NO:9 and SEQ ID NO: 10.
Patent AU-2012300037-A1 (AU)
Title: New additive for sugar manufacturing with cane, and preparation method therefor and application method thereof in sugar manufacturing
Inventor: ZHANG YONGDA
IPC: C13B20/08
Filed: 2012-06-15
Abstract: A new additive for sugar manufacturing with cane, and a preparation method therefor and an application method thereof in sugar manufacturing industry. The new preparation comprises raw materials of the following weight parts: concentrated phosphoric acid 100, chitosan 0.5-50, and a carrier raw material diatomite 15-90. The preparation method comprises: adding 0.5 to 50 weight parts of chitosan in 100 weight parts of concentrated phosphoric acid, and reacting for 30 to 120 min at a temperature of 8°C to 300°C, and then absorbing the product of the reaction by 15 to 90 weight parts of diatomite. In the industry of sugar manufacturing with cane, the new additive is used to completely replace sulfur dioxide to perform decoloration and clarification treatment on cane pressed juices and mixed juices thereof, and pre-heated and pre-pressed juices, and the new additive can also be used for retreatment of clean juices or syrup.
Patent AU-2012305097-A1 (AU)
Title: Wireless power receiver and control method thereof
Inventor: LEE KYUNG-WOO
IPC: H04B7/24
Filed: 2012-09-07
Abstract: Methods and apparatus are provided for controlling a wireless power receiver for wirelessly receiving power. A drive power for driving the wireless power receiver is received from a wireless power transmitter. A communication network is established with the wireless power transmitter. A wireless power network that is controlled by the wireless power transmitter is joined. A charge power is received from the wireless power transmitter.
Patent AU-2012314860-A1 (AU)
Title: Immunocytokine combination therapy
Inventor: SCHWAGER KATHRIN
IPC: A61K47/48
Filed: 2012-06-29
Abstract: Methods and compositions for treating tumours, especially skin tumours, by locally administering single doses of tumour necrosis factor alpha (TNFα) and interleukin-2 (IL2) at the tumour site, where the TNFα and IL2 are delivered as immunoconjugates comprising an antibody targeted to a splice isoform of an extracellular matrix component such as fibronectin.
Patent AU-2012322461-A1 (AU)
Title: Modular platform
Inventor: BAINES GURDIP SINGH
IPC: E04G5/02
Filed: 2012-10-15
Abstract: We provide a platform (10) comprising a deck element (14) having a load- bearing member (18) secured to at least one support beam (16) of the deck element (14), and a plurality of first connection arrangements, and a plurality of deck support members (30) each having a second connection arrangement, wherein the deck element (14) is moveable with respect to the plurality of deck support members (30) to connect the deck element (14) to the plurality of deck support members (30), and wherein each of the first connection arrangements is configured to engage a respective one of the second connection arrangements, the first connection arrangement being one of an engaging member (20) or a receiving formation (35), and the respective second connection arrangement being the other of an engaging member (20) or a receiving formation (35), such that movement of the engaging member (20) in a first engaging direction causes the engaging member (20) to engage the receiving formation (35), to restrict movement of the deck element (14) relative to the respective deck support member (30) in at least one plane.
Patent AU-2012323849-A1 (AU)
Title: Treatment of ocular disease
Inventor: PETERS KEVIN
IPC: A61K39/395
Filed: 2012-10-15
Abstract: Disclosed are methods for treating eye diseases or conditions characterized by vascular instability, vascular leakage, and neovacularization such as diabetic macular edema, age-related macular edema, choroidal neovascularization, diabetic retinopathy, trauma, ocular ischemia, and uveitis.
Patent AU-2012335072-A1 (AU)
Title: Digital-based medical devices
Inventor: WOOD ROBERT J
IPC: A61B3/00
Filed: 2012-11-09
Abstract: A medical device includes a housing, an imaging system having an electronic imager, an illumination system having at least one light source and an optional display in which the optical system includes a focusing mechanism. In one version, the focusing mechanism includes an optical focusing element such as at least one liquid lens assembly, to enable dynamic focusing and in another version a peripheral device is attached to the housing, the peripheral device having the electronic imager, display and processing logic.
Patent AU-2012335735-A1 (AU)
Title: Systems and methods for effecting good hygiene practices
Inventor: TENARVITZ HENRY J
IPC: G06Q50/22
Filed: 2012-11-08
Abstract: A networked system (100) and method for improving hygiene practices includes an interactive communication system of user devices (12) and an information engine (28). Wired and wireless data transmission methods are provided.
Patent AU-2012340107-A1 (AU)
Title: Polymer protein microparticles
Inventor: CHEN HUNTER
IPC: A61P27/02
Filed: 2012-11-18
Abstract: Microparticles containing a core of therapeutic protein and a cortex of a biocompatible and biodegradable polymer, and methods of making and using the microparticles are provided. The extended release of a therapeutic protein from the microparticles in a physiological solution is demonstrated over an extended period of time.
Patent AU-2012348706-A1 (AU)
Title: Dry gas seal for supercritical CO2 pump-high pressure buffer
Inventor: DEL VESCOVO CARLO
IPC: F16J15/34
Filed: 2012-11-27
Abstract: Presented are systems and methods for assuring a safe working condition of a dry gas seal when a pump/compressor is in a standstill condition. A small booster compressor 426 is added to boost the pressure of an intermediate buffer gas injected into the chamber between a primary seal 404 and a secondary seal 406 of the dry gas seal 400. Control components detect when the barrier gas pressure drops below a preconfigured value and when detected, closes a valve in a line to a flare safe area and turns on the compressor 426. The boosted intermediate buffer gas, Nitrogen or dry air, slows the flow of untreated process gas through the primary seal of the dry gas seal and prevents icing of the primary seal.
Patent AU-2012351977-A1 (AU)
Title: Stimulation of ovarian follicle development and oocyte maturation
Inventor: CHENG YUAN
IPC: C12N5/00
Filed: 2012-12-14
Abstract: Methods are provided for stimulating ovarian preantral and antral follicles in a mammal.
Patent AU-2012353058-A1 (AU)
Title: Novel oligonucleotide conjugates and use thereof
Inventor: CHAE JEIWOOK
IPC: A61K9/16
Filed: 2012-12-14
Abstract: The present invention provides a double helix oligo-RNA structure in which target-specific ligands are bonded to the double helix oligo-RNA structure in which high molecular compounds for improving the delivery of double helix oligo-RNA that can be valuably used in treating diseases, specifically, cancer, are covalently bonded. The present invention also provides a method for preparing the RNA structure and a target-specific double helix oligo-RNA delivery technology through said structure. Nanoparticles constituted by the double helix oligo-RNA structure to which ligands are bonded may efficiently deliver double helix oligo-RNA to a target, and thus may exhibit an activity of double helix oligo-RNA structure in a target cell even with an administration of double helix oligo-RNA of relatively lower concentration. The nanoparticles may prevent the delivery of non-specific double helix oligo-RNA to other organs and cells, and therefore, can be valuably used not only as a tool for double helix oligo-RNA for treating various diseases, specifically, cancer, but also as a new type of double helix oligo-RNA delivery system. The present invention also relates to hybrid conjugates in which a hydrophilic material and a hydrophobic material are connected to both ends of antisense oligonucleotide(ASO) through covalent bond so as to achieve in vivo stability of the ASO, and to a method for preparing the hybrid conjugates and to nanoparticles constituted by the conjugates. The conjugates between ASO and macromolecules according to the present invention may improve in vivo stability of ASO, and therefore, can efficiently deliver ASO for treatment into cells and may exhibit an activity of ASO even with an administration of a relatively lower concentration.
Patent AU-2012363686-A1 (AU)
Title: Selecting content formats based on predicted user interest
Inventor: SARUKKAI RAMESH R
IPC: G06Q50/10
Filed: 2012-12-26
Abstract: Methods, systems, and computer program products are provided for selecting content formats based on predicted user interest. One example method includes receiving a request to present additional content to a user in association with the user viewing a video content item during a session, identifying one or more candidate content formats, predicting a likelihood that the user will abandon the session for each candidate content format, selecting a format based at least in part on the predicting, determining when to present the additional content to the user, and presenting the additional content in accordance with the selected format.
Patent WO-2013120127-A1 (WO)
Title: Appareil et procédé utilisant un appareil pour l'éducation interactive
Inventor: RUBBO MICHAEL DATTILO
IPC: G09B1/00
Filed: 2013-02-11
Abstract: L'invention concerne un appareil (10) pour raconter de façon interactive une histoire, l'appareil (10) comprenant un concentrateur (12) conçu pour être porté par un utilisateur et un élément (14) s'étendant du concentrateur (12) de façon à être apte à tourner autour du concentrateur (12), l'élément (14) comprenant des indices (18) qui peuvent être sélectionnés pour fournir une entrée pour raconter l'histoire.
Patent AU-2013202272-A1 (AU)
Title: Crushing roll with edge protection
Inventor: HARBOLD KEITH
IPC: B02C4/28
Filed: 2013-04-02
Abstract: A grinding assembly (10) for the comminution of material that enhances the durability of the side edges of both a grinding roll (12) and a flange roll (14). Both 5 the grinding roll (12) and the flange roll (14) include a wear ring that is received within a side groove formed at each end of a cylindrical roll body (20). The wear ring includes a series of spaced receiving cavities that each receive a wear member. Each wear member (64) includes a radially outer surface and an axial end face to enhance the durability of the edge of the roll body (20). The edge ring 10 (52) is retained on the roll body by a series of connectors that pass through the edge ring. In the flange roll design, a flange ring (24) is attached to the roll body (2) by a series of connectors that also secure the edge ring to the roll body. *6 sEo
Patent AU-2013206220-A1 (AU)
Title: System and method for identifying a receiving aircraft during airborne fueling
Inventor: IVERSON DONALD G
IPC: B64D39/00
Filed: 2013-06-07
Abstract: SYSTEM AND METHOD FOR IDENTIFYING A RECEIVING AIRCRAFT DURING AIRBORNE FUELING A system for effecting automatic identifying of a receiving aircraft receiving fuel from a fuel delivery apparatus in a delivering aircraft during an airborne fueling operation includes: (a) a first unit coupled with the receiving aircraft; (b) a second unit coupled with the delivering aircraft; (c) a processing unit coupled with at least one of the first unit and the second unit. The first and second units cooperate to effect communicative coupling for conveying identifying information between the receiving aircraft and the delivering aircraft. The processing unit cooperates with at least one of the first unit and the second unit for employing the identifying information to effect the identifying.
Patent AU-2013206534-A1 (AU)
Title: The NDD returns the user to original location after taking each stride.
Inventor: XU ZULIN
IPC: G01C22/02
Filed: 2013-06-25
Abstract: The Null Displacement Device is a shoe size device with a series of motorised wheels attached to the bottom which are electrically powered by a rechargeable battery and controlled by a micro chip computer. The Null Displacement Device can be separated into 3 different compartments. Compartment one is the shoe into which the user will insert his foot. Compartment two is where the motorised wheels are fitted. Compartment three includes the rechargeable battery, sensors, micro chip computer and the motor. The sensors will detect the speed of each stride and send this information to the computer which then sends commands to the motor to adjust the speed of all the wheels in order to achieve null displacement. The sensors will also send the distance of the stride to the computer so that the brake mechanism will be engaged when the device is returned to its original position. The brake mechanism will disengage as soon as all of the wheels are lifted from the ground.
Patent AU-2013208260-A1 (AU)
Title: Leukotriene B4 antagonist compound
Inventor: STACK DOUGLAS RICHARD
IPC: C07C233/25
Filed: 2013-01-04
Abstract: The present invention provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof. Also, the present invention provides a pharmaceutical composition comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier. The present invention further provides methods for treating abdominal aortic aneurysm or atherosclerosis comprising administering a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof or a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound of Formula (I) or pharmaceutically acceptable salt thereof.
Patent AU-2013224689-A1 (AU)
Title: Implantable sling systems and methods
Inventor: FISCHER BRIAN G
IPC: A61F2/00
Filed: 2013-09-05
Abstract: IMPLANTABLE SLING SYSTEMS AND METHODS Various embodiments of sling or implant systems are provided. The sling or implant systems can be employed to treat incontinence, prolapse, and like conditions. A needle delivery device (12) can be included, wherein the delivery device includes a needle (18) and a rotatable sheath (22). The rotatable sheath (22) can rotate upon actuation relative to the needle to selectively deploy or disengage an implant anchor from the distal end of the needle (18). (NN (Ni (=N
Patent AU-2013225812-A1 (AU)
Title: Methods for the treatment of B cell-mediated inflammatory diseases
Inventor: SMITH ERNEST S
IPC: A61P37/00
Filed: 2013-03-01
Abstract: Methods for treating diseases associated with CXCL13 expression, including certain autoimmune and inflammatory diseases such as Sjogren's syndrome are provided herein. The methods comprise administering to a subject in need thereof an effective amount of an agent that inhibits CXCL13 activity. According to aspects of the invention illustrated herein, there is provided a method of treating, preventing, or reducing the exacerbation of a B-cell-mediated inflammatory condition in a subject, including administering to a subject an effective amount of an isolated binding molecule which specifically binds to CXCL13, wherein said molecule prevents or inhibits CXCL13 activity.
Patent AU-2013230585-A1 (AU)
Title: Surfactant additives for stimulating subterranean formation during fracturing operations
Inventor: VAN ZANTEN RYAN
IPC: C09K8/68
Filed: 2013-02-19
Abstract: The present invention relates to surfactant additives useful for restoring permeability of a subterranean formation and methods of use thereof. One embodiment of the present invention provides a method that includes providing a fracturing fluid having an aqueous fluid, and a microemulsion surfactant, wherein the fracturing fluid is substantially free of an organic solvent; and placing the fracturing fluid into a subterranean formation at a rate sufficient to create or enhance at least one fracture in the subterranean formation.
Patent AU-2013233119-A1 (AU)
Title: Communication control system and control device
Inventor: EMORI MOTOTSUGU
IPC: G06F13/00
Filed: 2013-03-07
Abstract: A communication control system includes a first control device; a second control device, wherein the first control device and the second control device are grouped together by group identification information; a detecting unit configured to detect image data displayed on a display unit connected to the first control device; a first communication control unit configured to establish a session for performing data communication with the second control device identified by the group identification information, and send the image data; and a display control unit configured to implement control to display the image data sent from the first communication control unit.
Patent AU-2013239861-A1 (AU)
Title: Methods and compositions for treating arteriosclerotic vascular diseases
Inventor: LIU SHENG-YUNG
IPC: A61K36/07
Filed: 2013-03-26
Abstract: The present invention provides methods and compositions for treating arteriosclerotic vascular diseases by cyclohexenone compounds. In some embodiments, the compound in the methods inhibits PDGF-stimulated smooth muscle cell proliferation or migration. In some embodiments, the atherosclerosis is associated with coronary artery disease, aneurysm, arteriosclerosis, myocardial infarction, embolism, stroke, thrombosis, angina, vascular plaque inflammation, vascular plaque rupture, Kawasaki disease, calcification or inflammation. In some embodiments, the compound lowers low-density lipoprotein (LDL) cholesterol in the subject. In some embodiments, the compound maintains a normal low-density lipoprotein (LDL) cholesterol level in the subject.
Patent AU-2013241168-A1 (AU)
Title: Disposable diaper
Inventor: SAKAGUCHI SATORU
IPC: A61F13/49
Filed: 2013-03-28
Abstract: The absorbent body (40) of this disposable diaper (10) is provided with: a first region (41) of which at least a portion is disposed at a groin region; a second region (42) having a lower bending rigidity than the first region and disposed at the front waist-encircling region side of the first region; and a third region (43) having a higher bending rigidity than the second region and disposed at the front waist-encircling region side of the second region. The boundary between the first region and the second region is disposed at a narrowed region, the boundary between the second region and the third region is disposed at the groin region side of the end (95R) at the groin region side of a target section (95), and the end (43R) at the front waist-encircling region side of the third region is disposed at the front waist-encircling region side of the end at the crotch region side of the target section (95).
Patent AU-2013241643-A1 (AU)
Title: Method for removing ink printed on plastic films
Inventor: FULLANA FONT ANDRES
IPC: B08B3/04
Filed: 2013-03-13
Abstract: Method for removing ink printed on plastic film comprising various physical/chemical treatments. The main steps in the method are: conditioning of the material, grinding, removal of ink from the film, washing the film, recovering the cleaning solution, recovering the pigment and drying the film. As a result of the method, it is possible to obtain, first, an ink-free plastic film and, second, the pigment. Said products may be reused in industry, thereby enhancing the value chain of the product.
Patent AU-2013249679-A1 (AU)
Title: Bump cut on hole edge
Inventor: KMIEC JR STANLEY J
IPC: A61B17/74
Filed: 2013-04-10
Abstract: A bone fixation device includes an elongated body having a first channel extending there through and configured for insertion into a bone, a first opening formed on a first side wall of the body, the first side wall facing a lateral direction when implanted in a target orientation within the bone and a second opening formed on a second side wall of the body opposite the first opening. A second channel extends through the body from the first opening to the second opening and is dimensioned to permit insertion of an implant there through. A first bump is positioned about a periphery of the first opening at a location at which a stress concentration would be a maximum if no such first bump were formed, the first bump being dimensioned to diffuse a concentration of stress about the periphery due to forces applied thereto by an implant extending through the second channel.
Patent AU-2013258083-A1 (AU)
Title: Care enzyme system
Inventor: LILLEY RICHARD ELLIOT
IPC: C11D3/386
Filed: 2013-05-07
Abstract: A low temperature active enzymatic fabric care composition comprising the combination of one or more primary care enzymes and one or more auxiliary care enzymes.
Patent AU-2013261006-A1 (AU)
Title: Method and system for determining and implementing a viable containment design of a data center
Inventor: SINGH UMESH
IPC: G06Q10/06
Filed: 2013-03-22
Abstract: A method and system is provided for determining a viable containment design of a data center and systematic implementation of the determined containment design in the data center. Particularly, the invention provides a method and system for collecting data pertaining to the design and operational parameters of the data center; enabling various containment design options using CFD based methodology; providing recommendations for a viable containment design and assisting systematic implementation of the recommendations of in the data center following an iterative procedure.